Samuel Linford, MD
Orthopaedic Surgery · Afton, WYNPI 1306091046
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (39.5%), education and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Zimmer Biomet at 44.0% of the total. Reporting peaked in 2022 at $3,839 and has fallen 91.4% since, to $331 in 2025.
Across 48 payments — averaging $159.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$3K
- Active Medical, LLC$2K
- Arthrex$1K
- Heron Therapeutics, Inc.$170
- Stryker$131
- Anika Therapeutics, Inc.$85
- plus $224 from 10 others
What the payments were for
- Travel & lodging$3,01639%
- Food & beverage$1,97426%
- Education$2,63334%
- Other$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 20 | $3,356 |
| Active Medical, LLC | 2 | $2,172 |
| Arthrex | 7 | $1,496 |
| Heron Therapeutics, Inc. | 3 | $170 |
| Stryker | 3 | $131 |
| Anika Therapeutics, Inc. | 1 | $85 |
| Medacta USA, Inc. | 1 | $37 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Solventum Corporation | 1 | $31 |
| Encore Medical, LP | 1 | $27 |
| Vertex | 1 | $23 |
| Orthofix Medical, Inc. | 2 | $17 |
| Bioventus LLC | 1 | $16 |
| Smith+Nephew | 1 | $14 |
| Pfizer | 1 | $13 |
| Welch Allyn | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$2,116
- Comprehensive Shoulder System$139
- ROSA$130
- COMPREHENSIVE$120
How this compares
$7,635 in reported general payments places this provider in the 80th percentile of 69 orthopaedic surgery providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 23 | $387 |
| Amoxicillin | 23 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Afton
- Kevin StuckiAfton$1K
- Christopher HillsJackson$107K
- Matthew FournierLaramie$34K
- Jaymeson ArthurCasper$30K
- Ryan AukermanLaramie$24K
- Robert GrunfeldGillette$17K
- Mark RyzewiczCody$14K
- Jory WasserburgerSheridan$12K
- Mark McKennaLaramie$10K
- Rafael WilliamsWilson$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.